12/12/2022
Yes. UNLESS your study meets ALL of the IND exemption criteria at 21 CFR 312.2(b)(1).
Note that only lawfully marketed drugs are eligible for an IND exemption. For example, a supplement is marketed as a dietary supplement, not as a drug; therefore, an IND application to FDA would be required to study the safety and effectiveness of a supplement to treat disease.
The final decision regarding whether you are required to obtain an IND may be made only by the FDA or an IRB.
Group (Subgroup): Faculty
Tag(s): FDA - Clinical Trial
Southern Illinois University Edwardsville is authorized to operate as a postsecondary educational institution by the Illinois Board of Higher Education.
We use cookies and other tracking technologies to improve your browsing experience on our website, to analyze our website traffic and to understand where our visitors originate.
By browsing our website, you consent to our use of cookies and other tracking technologies. For more about the information SIUE collects, visit our Web Privacy Notice.